We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio CHICAGO — In patients with chronic ...

The use of dual antiplatelet therapy (DAPT), either with clopidogrel or ticagrelor (Brilinta; AstraZeneca), appears to reduce the risk of failing saphenous vein grafts among patients who undergo CABG ...

In patients undergoing CABG surgery, the use of radial-artery grafts as a second conduit results in a lower incidence of adverse cardiac events and a higher patency rate at 5 years compared with ...

With a median follow-up of 10 years after coronary artery bypass grafting (CABG), patients who received a radial artery graft rather than a saphenous vein graft as a second conduit were less likely to ...

Peyronie's disease is a medically and surgically challenging condition to manage. Most surgical techniques to correct the penile deformity often shorten the penis and do not address the issue of ...

A novel device called venous external support (VEST) may lead to increased longevity and durability of saphenous (leg) vein grafting during coronary artery bypass surgery, according to a new trial ...

A novel, stent-shaped device that provides external buttressing to saphenous vein grafts placed during coronary artery bypass surgery was safe, but failed to improve 12-month patency of vein grafts, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio ANAHEIM, Calif. — Patients undergoing ...

After coronary artery bypass grafting (CABG), evolocumab did not reduce saphenous vein graft disease rates at 2 years compared with placebo, according to late-breaking research presented in a Hot Line ...